PMID: 11927273Apr 3, 2002Paper

Interleukin-5 and eosinophils as therapeutic targets for asthma

Trends in Molecular Medicine
Paul S FosterDianne C Webb

Abstract

Extensive clinical investigations have implicated eosinophils in the pathogenesis of asthma. In a recent clinical trial, humanized monoclonal antibody to interleukin (IL)-5 significantly limited eosinophil migration to the lung. However, treatment did not affect the development of the late-phase response or airways hyperresponsiveness in experimental asthma. Although IL-5 is a key regulator of eosinophilia and attenuation of its actions without signs of clinical improvement raises questions about the contribution of these cells to disease, further studies are warranted to define the effects of anti-IL-5 in the processes that lead to chronic asthma. Furthermore, eosinophil accumulation into allergic tissues should not be viewed as a process that is exclusively regulated by IL-5 but one in which IL-5 greatly contributes. Indeed, data on anti-IL-5 treatments (human and animal models) are confounded by the failure of this approach to completely resolve tissue eosinophilia and the belief that IL-5 alone is the critical molecular switch for eosinophil development and migration. The contribution of these IL-5-independent pathways should be considered when assessing the role of eosinophils in disease processes.

References

Sep 1, 1979·Molecular Immunology·D L WassomG J Gleich
Jan 30, 1992·The New England Journal of Medicine·D S RobinsonA B Kay
Jun 1, 1992·The American Review of Respiratory Disease·M AzzawiP K Jeffery
May 1, 1991·The Journal of Clinical Investigation·Q HamidP K Jeffery
Nov 1, 1990·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·P G GibsonJ A Denburg
Dec 1, 1990·The American Review of Respiratory Disease·M AzzawiA B Kay
Feb 1, 1990·The Journal of Allergy and Clinical Immunology·G J Gleich
Jan 1, 1988·The Journal of Experimental Medicine·A F LopezM A Vadas
May 1, 1988·The Journal of Allergy and Clinical Immunology·J B SedgwickW W Busse
Sep 1, 1988·The American Review of Respiratory Disease·N A FlavahanP M Vanhoutte
May 1, 1988·The Journal of Allergy and Clinical Immunology·G J GleichP M Vanhoutte
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·H D CampbellI G Young
Aug 1, 1986·The Journal of Allergy and Clinical Immunology·H OtsukaJ A Denburg
Dec 1, 1993·The American Review of Respiratory Disease·P J MauserW Kreutner
Dec 1, 1994·Current Opinion in Immunology·M C Seminario, G J Gleich
Jan 1, 1994·Annual Review of Immunology·B S BochnerL M Lichtenstein
Jan 1, 1993·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T IwamaA Koda
Jan 1, 1996·The Journal of Experimental Medicine·J M DrazenK F Austen
Mar 1, 1997·The Journal of Clinical Investigation·A W MouldP S Foster
Mar 1, 1997·American Journal of Respiratory and Critical Care Medicine·E HamelmannE W Gelfand
May 1, 1997·American Journal of Respiratory and Critical Care Medicine·N N JarjourW W Busse
Jan 28, 1998·American Journal of Respiratory and Critical Care Medicine·L J WoodP M O'Byrne
May 29, 1998·The New England Journal of Medicine·M E Rothenberg
Jun 25, 1998·American Journal of Respiratory Cell and Molecular Biology·L J WoodP M O'Byrne
Jan 1, 1997·Memórias do Instituto Oswaldo Cruz·J A DenburgP M O'Byrne
Nov 3, 1998·Immunology and Cell Biology·S P HoganP S Foster
Jun 8, 1999·Annual Review of Immunology·M Wills-Karp
Jul 10, 1999·The Journal of Allergy and Clinical Immunology·F R ShardonofskyD P Huston
Sep 30, 1999·American Journal of Respiratory Cell and Molecular Biology·M D InmanP M O'Byrne
Sep 30, 1999·American Journal of Respiratory Cell and Molecular Biology·E HamelmannE W Gelfand
Dec 22, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·K G TournoyR A Pauwels

❮ Previous
Next ❯

Citations

Jan 10, 2004·The Journal of Allergy and Clinical Immunology·Bruce S Bochner
Mar 20, 2003·Immunology Letters·Shigeharu UekiJunichi Chihara
Apr 4, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Svetlana P Chapoval, Chella S David
Dec 20, 2002·Nature·Kanade ShinkaiRichard M Locksley
Dec 12, 2003·Nature Reviews. Drug Discovery·Stephen T Holgate, David Broide
Oct 31, 2002·American Journal of Respiratory and Critical Care Medicine·Richard LeighPaul M O'Byrne
Dec 6, 2003·American Journal of Respiratory and Critical Care Medicine·Sandra C DormanPaul M O'Byrne
Aug 13, 2004·American Journal of Respiratory and Critical Care Medicine·Rakesh K KumarPaul S Foster
Jun 11, 2003·American Journal of Respiratory and Critical Care Medicine·A Barry Kay, Andrew Menzies-Gow
Sep 28, 2007·BMC Immunology·Georgina M SansomeRobert J Bischof
Mar 19, 2003·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Robert Newton, Neil Holden
Mar 5, 2004·Expert Opinion on Investigational Drugs·Hans Michael Haitchi, Stephen T Holgate
Mar 23, 2012·Trends in Immunology·Stephen T Holgate
Aug 3, 2011·The Journal of Allergy and Clinical Immunology·Stephen T Holgate
Nov 21, 2007·European Journal of Pharmacology·Alexandre P RogerioLúcia H Faccioli
Dec 21, 2004·Alimentary Pharmacology & Therapeutics·S P Hogan, M E Rothenberg
Oct 17, 2006·Biopolymers·Madhushree BhattacharyaIrwin Chaiken
Jan 15, 2011·British Journal of Pharmacology·Philip M HansbroPaul S Foster
Nov 21, 2012·British Journal of Clinical Pharmacology·Stephen T Holgate
Apr 4, 2016·European Journal of Pharmacology·Lais Costa AgraEmiliano Barreto
Oct 12, 2004·Immunology and Allergy Clinics of North America·A Barry Kay, Amy D Klion
Mar 27, 2015·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·E A GaillardM D Shields
Nov 7, 2012·Expert Opinion on Investigational Drugs·Philip M HansbroPaul S Foster
Jan 8, 2013·Expert Opinion on Biological Therapy·Massimo CarusoRiccardo Polosa
Sep 1, 2006·Expert Review of Clinical Immunology·Osamu KaminumaAkio Mori
Jul 31, 2004·Medical Mycology·G T ColeC Y Hung
Oct 4, 2006·International Archives of Allergy and Immunology·Luciana M C Vasquez-PintoSonia Jancar
May 15, 2019·Current Opinion in Allergy and Clinical Immunology·Chengshuo Wang, Luo Zhang
Oct 12, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Peter J HenryRoy G Goldie
Sep 25, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Kei TakemotoHironobu Ishiyama
Apr 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elizabeth ForbesSimon P Hogan
Jul 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paul M ArnaboldiDennis W Metzger
Jan 20, 2017·Microbiology Spectrum·Bart N LambrechtHamida Hammad
Oct 27, 2021·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Peng QiDianbo Kou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.